TUMMYTOX blogs.

Why celebrities are risking it with semaglutide injections – and what you should do instead

It’s no secret we’re all searching for a fast-acting and efficient magic spell to drop the weight. The hottest trend right now is the infamous solution, used by our favourite celebrities and influencers.

Weight-loss injections have taken over the world, showcasing fast and jaw-dropping results. But the hype was shut down by the media and negative testimonials, reporting intimidating side effects: sagging face, vomiting, fatigue, and pancreatitis, to name a few.

That's why people have turned away from artificial solutions and begun searching for natural ways to boost their satiety hormone. Could nature really outshine the semaglutide injections? Read on to find out what science says!

everything you need to know about GLP-1 supplements

The abuse of semaglutide injections

Many well-respected doctors have warned against the abuse of these injections. These medications were primarily developed to treat type 2 diabetes by lowering blood sugar levels and helping the pancreas create more insulin.

Prescription medications like semaglutide mimic the effects of GLP-1. These medications slow digestion and signal the brain to stop eating, which leads to weight loss. That's why GLP-1 is also called the satiety hormone.

But the side effects are hard to ignore: nausea, dizziness, bloating, fatigue, and even hair loss. Plus, when the injections stop, the pounds often return – which is exactly the opposite of our deepest wishes.

So, why do celebrities take the risk? Simple: it’s fast. But these shortcuts come at the cost of your well-being and wallet. These injections force your body to work unnaturally when it could be supported to function optimally on its own.

What is GLP-1 and why is it so important for weight loss

You hadn’t heard of GLP-1 before the rise of weight-loss injections, but the plot twist is that you’ve had it in your body all along.

GLP-1 (glucagon-like peptide-1) is a natural hormone made by your intestines and released after eating. Its main role is to trigger the release of insulin, a hormone that helps move glucose from the bloodstream into the body’s cells to be used as energy.

If you’re wondering how to eat less, your satiety hormone can do the trick by:

  • Suppressing appetite by signalling your brain that you’re full, so you naturally eat less.

  • Regulating blood sugar, leading to fewer energy crashes, and most importantly, helping you avoid sugary snacks.

  • Supporting weight loss efforts by putting hunger under control and balancing blood sugar, so you can calmly focus on healthy and sustainable weight loss.

To top it all off, GLP-1 also slows gastric emptying – the process where the stomach empties its contents into the small intestine. This prolongs feelings of fullness and solves the mystery of how to stop overeating.

Dysregulated GLP-1 levels often lead to uncontrollable cravings and energy slumps, making weight control nearly impossible. This is where weight-loss injections claim to help – but the truth is, your body can boost GLP-1 on its own with the right support.

You don’t need needles to boost GLP-1 – Try this natural alternative instead

Following the backlash of semaglutide side effects, nutritional experts turned to ancient wisdom and discovered two plants that mimic the effects of injections without the unwanted side effects.

White mulberry, originally known as Sang Ye(桑叶), has been traditionally used in Chinese medicine for balancing blood sugar levels, improving digestion, and managing diabetes.

Modern scientists have proven white mulberry’s power in influencing your satiety hormone GLP-1:

  • It slows the breakdown of carbs and ensures that sugar enters the bloodstream slowly,

  • in response, your body releases more GLP-1, which results in smaller sugar spikes and prolonged feelings of fullness.

For the cherry on top, a clinical study has proven, that white mulberry leaf extract reduced peak blood sugar levels by a whopping 42% and peak insulin levels by 41%! Research also proved that participants lost an average of 9 kilograms in just 3 months when supplementing with it.

Another, even older plant, originates from traditional Ayurvedic medicine. Berberine, from Indian barberry (Daruharidra), is famous for its effects on blood sugar control and GLP-1 interaction. It has been used for centuries to lower cholesterol, blood sugar, and triglyceride levels.

Scientific studies show that berberine not only boosts GLP-1 production from intestinal cells, improving insulin sensitivity by an average of 20.8% and helping to control appetite, but it also reduces cholesterol levels by 23% and blood triglycerides by 12.2%. On top of that, berberine has been proven to support weight loss by helping you lose an average of 3.5% of pure body fat.

Why choose GLP-1 supplements over injections?

In a clinical study with over 200 participants, researchers found that berberine can be as effective as popular diabetes medications at reducing blood glucose. Combined with white mulberry, it supports weight loss and long-term health—without the high costs or side effects like sagging skin or the yo-yo effect often seen with weight-loss injections.

When combined, white mulberry and berberine mimic the appetite-suppressing and blood-sugar-balancing benefits of medications, but without the downsides. Best of all, a potent GLP-1 supplement with both these superstars is natural, affordable, and easy to incorporate in your daily routine!

GLP-1 Balance: A smarter, cheaper, and much safer way to drop kilos

You deserve the same chance for weight-loss success as celebrities (but without the hefty price tag or side effects).

That's why we developed GLP-1 Balance with amazing benefits for your health:

  • Stimulates GLP-1 release and boosts satiety

  • Slows down carbohydrate digestion and blocks sugar spikes

  • Balances gut microbiome, triglycerides, and blood sugar

GLP-1 Balance is packed with 500 mg of berberine and 250 mg of patented white mulberry leaf extract (Reducose®) with clinically proven effects:

  • Boosts satiety hormone GLP-1 by an astronomical 65*%

  • Helps you lose up to 2.3* kg of body weight

  • Lowers glucose and insulin levels by up to 42*%

Most importantly, it eliminates cravings and blocks appetite, so you can easily reach a caloric deficit!

To make its formulation even more powerful, our nutrition experts enriched it with chromium to support macronutrient metabolism and regulate blood sugar levels.

Black pepper extract with piperine improves the absorption of the two superstars in GLP-1 Balance by an impressive 30%!

The answer to how to stop overeating is GLP-1 Balance– your stomach-friendly and hormone-free solution for achieving weight goals and finally being confident in your body.

Sources

Thaipitakwong, T., Numhom, S., & Aramwit, P. (2018). Mulberry leaves and their potential effects against cardiometabolic risks: a review of chemical compositions, biological properties and clinical efficacy. Pharmaceutical Biology, 56(1), 109–118. https://doi.org/10.1080/13880209.2018.1424210

Thondre, P.S., Lightowler, H., Ahlstrom, L. et al. Mulberry leaf extract improves glycaemic response and insulaemic response to sucrose in healthy subjects: results of a randomized, double blind, placebo-controlled study. NutrMetab (Lond)18, 41 (2021). https://doi.org/10.1186/s12986-021-00571-2

Utami, A. R., Maksum, I. P., & Deawati, Y. (2023). Berberine and Its Study as an Antidiabetic Compound. Biology, 12(7), 973. https://doi.org/10.3390/biology12070973

Hu, Yueshan & Ehli, Erik & Kittelsrud, Julie & Ronan, Patrick & Munger, Karen & Downey, Terry & Bohlen, Krista & Callahan, Leah & Munson, Vicki & Jahnke, Mike & Marshall, Lindsey & Nelson, Kelly & Huizenga, Patricia & Hansen, Ryan & Soundy, Timothy & Davies, Gareth. (2012). Lipid-lowering effect of berberine in human subjects and rats. Phytomedicine : international journal of phytotherapy and phytopharmacology. 19. 861-7. 10.1016/j.phymed.2012.05.009.

Sanjari, M., Shamsinejad, B., Khazaeli, P. et al. Safety and efficacy of Berberis integerrima root extract in patients with type 2 diabetes. A parallel intervention based triple blind clinical trial. J Diabetes MetabDisord 19, 71–80 (2020). https://doi.org/10.1007/s40200-019-00478-z

Gheldof N, Francey C, Rytz A, Egli L, Delodder F, Bovetto L, Piccardi N, Darimont C. Effect of Different Nutritional Supplements on Glucose Response of Complete Meals in Two Crossover Studies. Nutrients. 2022 Jun 28;14(13):2674. doi: 10.3390/nu14132674. PMID: 35807854; PMCID: PMC9268658.

Mohamed M, Zagury RL, Bhaskaran K, Neutel J, Mohd Yusof BN, Mooney L, Yeo L, Kirwan BA, Aprikian O, von Eynatten M, Johansen OE. A Randomized, Placebo-Controlled Crossover Study to Evaluate Postprandial Glucometabolic Effects of Mulberry Leaf Extract, Vitamin D, Chromium, and Fiber in People with Type 2 Diabetes. Diabetes Ther. 2023 Apr;14(4):749-766. doi: 10.1007/s13300-023-01379-4. Epub 2023 Mar 1. PMID: 36855010; PMCID: PMC10064401.

Lown M, Fuller R, Lightowler H, Fraser A, Gallagher A, Stuart B, Byrne C, Lewith G. Mulberry-extract improves glucose tolerance and decreases insulin concentrations in normoglycaemic adults: Results of a randomised double-blind placebo-controlled study. PLoS One. 2017 Feb 22;12(2):e0172239. doi: 10.1371/journal.pone.0172239. PMID: 28225835; PMCID: PMC5321430.

Ding F, Wang Q, Xie C, Wang M, Zhang L, Gao M, Yang Z, Ma J, Shi X, Chen W, Duan S, Yuan P, Li Y, Ma X, Wu Y, Liu J, Feng X, Cheng Q, Wang Z, Li X, Huang J. The impact of mulberry leaf extract at three different levels on reducing the glycemic index of white bread. PLoS One. 2023 Aug 10;18(8):e0288911. doi: 10.1371/journal.pone.0288911. PMID: 37561734; PMCID: PMC10414662.

Belwal T, Bisht A, Devkota HP, Ullah H, Khan H, Pandey A, Bhatt ID, Echeverría J. Phytopharmacology and Clinical Updates of Berberis Species Against Diabetes and Other Metabolic Diseases. Front Pharmacol. 2020 Feb 18;11:41. doi: 10.3389/fphar.2020.00041. PMID: 32132921; PMCID: PMC7040237.

Affuso F, Mercurio V, Fazio V, Fazio S. Cardiovascular and metabolic effects of Berberine. World J Cardiol. 2010 Apr 26;2(4):71-7. doi: 10.4330/wjc.v2.i4.71. PMID: 21160701; PMCID: PMC2999047.

Zhang L, Wu X, Yang R, Chen F, Liao Y, Zhu Z, Wu Z, Sun X, Wang L. Effects of Berberine on the Gastrointestinal Microbiota. Front Cell Infect Microbiol. 2021 Feb 19;10:588517. doi: 10.3389/fcimb.2020.588517. PMID: 33680978; PMCID: PMC7933196.

Yang F, Gao R, Luo X, Liu R, Xiong D. Berberine influences multiple diseases by modifying gut microbiota. Front Nutr. 2023 Aug 3;10:1187718. doi: 10.3389/fnut.2023.1187718. PMID: 37599699; PMCID: PMC10435753.

Müller TD, Finan B, Bloom SR, D'Alessio D, Drucker DJ, Flatt PR, Fritsche A, Gribble F, Grill HJ, Habener JF, Holst JJ, Langhans W, Meier JJ, Nauck MA, Perez-Tilve D, Pocai A, Reimann F, Sandoval DA, Schwartz TW, Seeley RJ, Stemmer K, Tang-Christensen M, Woods SC, DiMarchi RD, Tschöp MH. Glucagon-like peptide 1 (GLP-1). Mol Metab. 2019 Dec;30:72-130. doi: 10.1016/j.molmet.2019.09.010. Epub 2019 Sep 30. PMID: 31767182; PMCID: PMC6812410.

Mysels DJ, Sullivan MA. The relationship between opioid and sugar intake: review of evidence and clinical applications. J Opioid Manag. 2010 Nov-Dec;6(6):445-52. doi: 10.5055/jom.2010.0043. PMID: 21269006; PMCID: PMC3109725.

Schulte EM, Gearhardt AN. Associations of Food Addiction in a Sample Recruited to Be Nationally Representative of the United States. Eur Eat Disord Rev. 2018 Mar;26(2):112-119. doi: 10.1002/erv.2575. Epub 2017 Dec 21. PMID: 29266583.

Shi A, Deng J, Ma J, Yang L, Tantai X, Wang Q, Chang D, Wang J, Guo X, Lu X, Shi H. Prevalence and Risk Factors of Metabolic Dysfunction-Associated Fatty Liver Disease with Renal Insufficiency in Overweight/Obese Adults. Obes Facts. 2023;16(6):548-558. doi: 10.1159/000533626. Epub 2023 Aug 28. PMID: 37640023; PMCID: PMC10697752.

Scuteri A, Laurent S, Cucca F, Cockcroft J, Cunha PG, Mañas LR, Mattace Raso FU, Muiesan ML, Ryliškytė L, Rietzschel E, Strait J, Vlachopoulos C, Völzke H, Lakatta EG, Nilsson PM; Metabolic Syndrome and Arteries Research (MARE) Consortium. Metabolic syndrome across Europe: different clusters of risk factors. Eur J Prev Cardiol. 2015 Apr;22(4):486-91. doi: 10.1177/2047487314525529. Epub 2014 Mar 19. PMID: 24647805; PMCID: PMC4544872.

Yueshan Hu, Erik A. Ehli, Julie Kittelsrud, Patrick J. Ronan, Karen Munger, Terry Downey, Krista Bohlen, Leah Callahan, Vicki Munson, Mike Jahnke, Lindsey L. Marshall, Kelly Nelson, Patricia Huizenga, Ryan Hansen, Timothy J. Soundy, Gareth E. Davies, Lipid-lowering effect of berberine in human subjects and rats,

Phytomedicine, Volume 19, Issue 10, 2012, Pages 861-867, ISSN 0944-7113, https://doi.org/10.1016/j.phymed.2012.05.009.